[144] Gevo, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Gevo, Inc. (GEVO) indicates a proposed sale of 225,000 shares of common stock through Stifel Nicolaus & Company, with an aggregate market value of $451,305.00. The shares are scheduled for sale approximately on 09/17/2025 on the Nasdaq. The filing states the securities were acquired as Restricted Stock Units on 08/20/2021 from the issuer, totaling 392,175 shares acquired on that date and with cash payment noted.

The filing also discloses recent sales by the same person, Paul Bloom, totaling several transactions in August and September 2025 (largest single prior sale listed: 33,073 shares on 08/05/2025). The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Routine insider sale of vested RSUs; size is small relative to total shares outstanding, suggesting limited market impact.

The filing shows a proposed sale of 225,000 shares (aggregate value $451,305) executed via a broker and originating from RSUs granted on 08/20/2021. Relative to reported outstanding shares (239,562,995), the proposed sale represents roughly 0.094% of the outstanding float, which is immaterial from a dilution or supply-demand perspective. Recent prior sales by the same person in August and September 2025 are disclosed, indicating ongoing monetization of equity rather than a single large divestiture. From a financial viewpoint, this appears as standard executive/shareholder liquidity activity rather than a signal of company-specific financial stress.

Corporate Governance Expert

TL;DR: Filing meets Rule 144 disclosure requirements; shows RSU-originated shares and recent sales history for transparency.

The notice properly identifies the broker, planned sale date, class of security, acquisition method (Restricted Stock Units), and past three months of sales by the same person. This level of disclosure aligns with governance best practices for insider transactions and Rule 144 compliance. The seller’s signed representation regarding absence of undisclosed material information is included as required. There is no indication in the form of any plan adoption date or 10b5-1 reliance noted, so the sales appear to be reported as ad-hoc or standard reported sales rather than under a pre-committed trading plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	225000	451305.00	239562995	09/17/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/20/2021	Restricted Stock Units	Issuer			392175	08/20/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Paul Bloom 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	09/04/2025	414	675.00
Paul Bloom 346 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	09/04/2025	1678	2734.00
Paul Bloom 347 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	08/05/2025	33073	40700.00
Paul Bloom 348 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	08/05/2025	9000	10897.00
Paul Bloom 349 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	08/01/2025	27744	34760.00
Paul Bloom 350 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	08/01/2025	5411	6791.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)